//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~subject:"Afatinib"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: person:"Postma, Maarten J."
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Afatinib
Cost-effectiveness
11
Netherlands
4
Niederlande
4
Cost-analysis
3
Cost-effectiveness analysis
3
Economic-implications
3
Gesundheitsvorsorge
3
Gesundheitsökonomik
3
Health economics
3
Kosten-Wirksamkeits-Analyse
3
Pharmacoeconomics
3
Preventive care
3
Arzneimittel
2
Cancer
2
Cost effectiveness
2
Discount-rate
2
Elderly
2
Gesundheitskosten
2
Haematological-malignancies
2
Health care costs
2
Infants
2
Infectious disease
2
Infektionskrankheit
2
Krebskrankheit
2
Meningitis
2
Mycoses
2
Pharmaceuticals
2
Vaccines
2
177Lu-DOTATATE
1
ACE-inhibitors
1
Age-specific wages
1
Aging population
1
Alternde Bevölkerung
1
Angiotensin-II-receptor-antagonists
1
Anreiz
1
Antifungals
1
Antineoplastics
1
Antiretrovirals
1
Arbeitsproduktivität
1
more ...
less ...
Online availability
All
Undetermined
1
Type of publication
All
Article
1
Type of publication (narrower categories)
All
Article in journal
1
Aufsatz in Zeitschrift
1
Language
All
English
1
Author
All
Griebsch, Ingolf
1
Nicolai, Jelmer L. J.
1
Postma, Maarten J.
1
Postmus, Pieter E.
1
Samuelsen, Carl
1
Smit, Hans J. M.
1
Westerink, Lotte
1
more ...
less ...
Published in...
All
The European journal of health economics : HEPAC ; health economics in prevention and care
1
Source
All
ECONIS (ZBW)
1
Showing
1
-
1
of
1
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations
Westerink, Lotte
;
Nicolai, Jelmer L. J.
;
Samuelsen, Carl
; …
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
6
,
pp. 931-943
Persistent link: https://www.econbiz.de/10012489821
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->